All the news Showing 10 of 156 articles from: United StatesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Kidney disease & HCV Higher kidney disease risk persists in people cured of hepatitis C Keith Alcorn / 19 July 2022 People with hepatitis C remain at higher risk of chronic kidney disease after clearing or being cured of hepatitis C and people with genotype 1 infection have a higher risk of kidney ... Starting treatment Why do people with HIV delay hepatitis C treatment? Keith Alcorn / 15 July 2022 Greater efforts by healthcare providers to build trusting relationships with people with HIV and hepatitis C, together with a greater focus on overcoming concerns about treatment side effects, are likely to be needed ... Treatment in liver transplanted Short-course treatment prevents hepatitis C after organ transplant Keith Alcorn / 24 June 2022 A seven-day course of direct-acting antiviral treatment started hours before an organ transplant prevented hepatitis C infection in everyone who received a transplant from a donor with hepatitis C, researchers from the Mayo ... Treatment for people who use drugs Accessible care achieves higher hepatitis C cure rate in people who inject drugs Keith Alcorn / 28 March 2022 Hepatitis C care located within a needle and syringe programme in New York achieved a three times higher cure rate than referral to a patient navigator and linkage to medical care at ... Coronavirus COVID-19 pandemic led to a 30% drop in new hepatitis C treatments in the United States Keith Alcorn / 22 March 2022 Hepatitis C testing and treatment initiations in the United States dropped by 30% at the beginning of the COVID-19 pandemic in 2020 and treatment initiations did not recover to previous levels during ... Screening policy Universal hepatitis C screening in pregnancy improves case detection Keith Alcorn / 23 February 2022 Implementing universal testing for hepatitis C during pregnancy improved case detection 7.5-fold compared to the previous regime of risk-based screening, a research group from the University of Pittsburgh reported last week at the ... Injecting drug use One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... Hepatocellular carcinoma (HCC) Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Treatment for previous non-responders & relapsers Three-drug regimen plus ribavirin cures the hardest-to-treat hepatitis C patients Keith Alcorn / 08 December 2021 People who have experienced failure of multiple courses of direct-acting antiviral treatment can be cured of hepatitis C with a combination of three direct-acting antivirals plus ribavirin, a review of heavily treatment-experienced patients ... Advanced fibrosis in people with NAFLD increases the risk of liver complications Keith Alcorn / 08 December 2021 Advanced liver fibrosis in people with non-alcoholic fatty liver disease was associated with an increased risk of liver-related complications, a prospective study in the United States has found. Fat accumulation in the liver, ... ← First12345...16Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive